AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruno, R. S
Right arrow Articles by Traber, M. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruno, R. S
Right arrow Articles by Traber, M. G
Agricola
Right arrow Articles by Bruno, R. S
Right arrow Articles by Traber, M. G
American Journal of Clinical Nutrition, Vol. 81, No. 5, 1052-1059, May 2005
© 2005 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Lower plasma {alpha}-carboxyethyl-hydroxychroman after deuterium-labeled {alpha}-tocopherol supplementation suggests decreased vitamin E metabolism in smokers1,2,3

Richard S Bruno, Scott W Leonard, Jun Li, Tammy M Bray and Maret G Traber

1 From the Linus Pauling Institute, Oregon State University, Corvallis, OR (RSB, SWL, TMB, and MGT), and Roswell Park Cancer Institute, Buffalo, NY (JL)

Background: Cigarette smoking increases the fractional disappearance rates of {alpha}-tocopherol and is associated with increased oxidative stress, but its effects on {alpha}-tocopherol metabolism are unknown.

Objective: We hypothesized that smokers would have less {alpha}-tocopherol available and consequently lower plasma {alpha}-carboxyethyl-hydroxychroman ({alpha}-CEHC), the {alpha}-tocopherol metabolite produced by a cytochrome P450–mediated process.

Design: Smokers and nonsmokers (n = 10 per group) were supplemented with deuterium-labeled {alpha}-tocopheryl acetates (75 mg each d3-RRR-{alpha}-tocopheryl and d6-all-rac-{alpha}-tocopheryl acetate) from day –6 to day –1, and plasma tocopherols and CEHCs were measured (day –6 through day 17).

Results: After 6 d of supplementation, plasma d3- and d6-{alpha}-tocopherol concentrations did not differ significantly between groups. Plasma d3- and d6-{alpha}-CEHCs were detectable only from day –5 to day 5. Before supplementation, unlabeled {alpha}- and {gamma}-CEHCs were {approx}60% and 40% lower, respectively, in smokers than in nonsmokers (P ≤ 0.05). In addition, d0-, d3-, and d6-{alpha}-CEHC areas under the curves were {approx}50% lower in smokers (P < 0.05), and smokers had lower maximal d3-{alpha}-CEHC (P = 0.004) and d6-{alpha}-CEHC (P = 0.0006) concentrations. Notably, 2.9–4.7 times as much {alpha}-CEHC was produced from all-rac-{alpha}-tocopherol than from RRR-{alpha}-tocopherol. During supplementation, smokers had about one-half (P < 0.05) the plasma total, d6-, or d3-{alpha}-CEHC concentrations that nonsmokers did given similar {alpha}-tocopherol concentrations.

Conclusions: Smoking did not increase {alpha}-tocopherol disappearance through P450-mediated tocopherol metabolism. Therefore, the mechanism of increased {alpha}-tocopherol disappearance in smokers likely operates through oxidation pathways, which is consistent with {alpha}-tocopherol’s antioxidant function. Consequently, evaluating the molecular mechanism or mechanisms responsible for tocopherol metabolism under conditions of oxidative stress and the mechanisms that regulate {alpha}-tocopherol status is warranted.

Key Words: Oxidative stress • carboxyethyl-hydroxychroman • CEHC • smokers • tocopherols • metabolism • cytochrome P450




This article has been cited by other articles:


Home page
J. Nutr.Home page
R. S. Bruno, C. E. Dugan, J. A. Smyth, D. A. DiNatale, and S. I. Koo
Green Tea Extract Protects Leptin-Deficient, Spontaneously Obese Mice from Hepatic Steatosis and Injury
J. Nutr., February 1, 2008; 138(2): 323 - 331.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. J Clifford, F. F de Moura, C. C Ho, J. C Chuang, J. Follett, J. G Fadel, and J. A Novotny
A feasibility study quantifying in vivo human {alpha}-tocopherol metabolism
Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1430 - 1441.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. W Clarke, N. C Ward, J. H. Wu, J. M Hodgson, I. B Puddey, and K. D Croft
Supplementation with mixed tocopherols increases serum and blood cell {gamma}-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes
Am. J. Clinical Nutrition, January 1, 2006; 83(1): 95 - 102.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The American Society for Nutrition